SKIM appoints Robert Wucher as Senior Director - DACH region
SKIM welcomes Robert Wucher as Senior Director in Berlin to lead commercial growth and client partnerships across the DACH region.
Organized by Pharmaceutical Market Research Group, the panel of experts will help you navigate the uncertainty and red tape that makes data collection and insights delivery in pharma, medical devices, and finance an ongoing challenge.
Speakers:
– Steve Cooley, Ph.D. – Divisional VP, Blue Cross/Blue Shield of Illinois
– Rosie Balk – Lead, Global Marketing Research, Biotherapeutics & Transplant Immunology, Shire
– Bill Salokar – VP Client Solutions, SKIM
Optimizing insights in highly regulated industries
This session answered, among others, the following questions:
- Working in a highly regulated industry like insurance, pharmaceuticals, and finance comes with challenges, what are the biggest challenges associated with being regulated and how do they impact the research you do?
- To work in this industry, suppliers have to be aware of regulations unique to your industry. What are the expectations for current and potential suppliers?
- With the constraints in place, what steps​ do you take to ensure you get as much as possible out of the research you conduct? In other words, how do you optimize your insights?
- Does working in pharma and insurance mean that you can’t take advantage of some of the newer and more innovative research techniques available today?
- And looking at where we are today, are things getting better or worse, easier or more challenging?
